References
- Aya AG, Mangin R, Hoffet M, et al. Intravenous nicardipine for severe hypertension in pre-eclampsia–effects of an acute treatment on mother and foetus. Intensive Care Med 1999;25:1277–81
- Bartels PA, Hanff LM, Mathot RAA, et al. Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk. BJOG 2007;114:230–3
- Carbonne B, Jannet D, Touboul C, et al. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993;81:908–14
- Jannet D, Carbonne B, Sebban E, et al. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354–59
- Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzyme and low platelet count. Obstet Gynecol 2004;103:981–91
- Itabashi K, Fujimura M, Kusuda S, et al. Introduction of a new birth weight standard according to the gestational age. Report from the Council of Neonate, Japan Pediatric Society. Acta Paediatrica Japonica 2010;114:1271–93. (in Japanese)
- Ostrea EM Jr, Mantaring JB III, Silvestre MA. Drugs that affect the fetus and newborn infant via the placenta or breast milk. Pediatr Clin North Am 2004;51:539–79
- Lindheimer MD, Taler SJ, Cunningham FG. American Society of Hypertension. ASH position paper: hypertension in pregnancy. J Clin Hypertens 2009;11:214–25
- Lowe SA, Brown MA, Dekker GA, et al. Society of Obstetric Medicine of Australia and New Zealand. Guidelines for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynecol 2009;49:242–6
- Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. NICE Clinical Guidelines, No. 107. London: RCOG Press, 2010
- Magee LA, Helewa M, Moutquin JM, et al. Hypertension guideline committee; strategic training initiative in research in the reproductive health sciences (STIRRHS) scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30:S1–48
- Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487–514
- Anderson GD, Carr DB. Effect of pregnancy on the pharmacokinetics of antihypertensive drugs. Clin Pharmacokinet 2009;48:159–68
- Hebert MF, Easterling TR, Kirby B, et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a university of Washington specialized center of research study. Clin Pham Ther 2008;84:248–53
- Modi N, Veng-Pedersen P, Graham DJ. Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy males. J Pharm Sci 1993;82:705–13
- Higuchi S, Shiobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 1980;10:447–54